Vulnerability · CVE-2025-36153
IBM Concert 1.0.0 through 2.0.0 is vulnerable to cross-site scripting.
Published Nov 20, 2025 · catalog updated Nov 20, 2025 · IBM Concert
Last checked Oct 28, 2026. A connected source was read within the last 7 days.
Check this week
CVE-2025-36153 is not in CISA KEV. FIRST estimates a 21.00% chance of exploitation in the next 30 days. Check whether you run IBM Concert.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
Same product and reporting
- CVE-2025-36150 · Medium
- CVE-2025-36158 · Medium
- CVE-2025-36159 · Medium
- CVE-2025-36160 · Medium
- CVE-2025-36161 · Medium
- Severity
- Medium6.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 21.00%
- Remediation
- Vendor / distro source
- Affected products
- vendor IBM Concert 1.0.0 ≤2.0.0
IBM Concert 1.0.0 through 2.0.0 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor IBM Concert 1.0.0 ≤2.0.01.0.0 ≤2.0.0
How to fix CVE-2025-36153
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
Seen in 1.0.0 ≤2.0.0
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2025-36153 is not in CISA KEV. FIRST estimates a 21.00% chance of exploitation in the next 30 days. Check whether you run IBM Concert.
Which versions are affected?
Compare what you have installed with IBM Concert 1.0.0 ≤2.0.0 1.0.0 ≤2.0.0. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 21.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Nov 20, 2025 · EUVD
Detected
IBM Concert 1.0.0 through 2.0.0 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Nov 20, 2025 · EUVD
Updated
IBM Concert 1.0.0 through 2.0.0 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Sources
- CVE.orgVulnerability recordCVE-2025-36153
Official CVE identifier
cve.org - EUVDVulnerability recordEUVD-2025-198360
IBM Concert 1.0.0 through 2.0.0 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted se
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Nov 20, 2025. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- CVE.orgOct 28, 2026
- EUVDOct 28, 2026